Ashton Paul

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
12
Insider Sells Sum
$1.17M

Insider Activity of Ashton Paul

The largest sale of all time was on 2015-12-22 and amounted to 240000 shares of EyePoint Pharmaceuticals, Inc. for $782,400.

Biography of Ashton Paul

No biography is available at this moment.

2015-12-22SaleEyePoint Pharmaceuticals, Inc.
EYPT
President & CEO
240,000
0.592%
$3.26$782,400-32.96%
2014-10-01SaleEyePoint Pharmaceuticals, Inc.
EYPT
President & CEO
20,000
0.0454%
$2.70$54,000-0.25%
2014-09-02SaleEyePoint Pharmaceuticals, Inc.
EYPT
President & CEO
20,000
0.0422%
$2.96$59,100-15.06%
2014-08-01SaleEyePoint Pharmaceuticals, Inc.
EYPT
President & CEO
20,000
0.0428%
$2.75$55,000-7.08%
2014-07-01SaleEyePoint Pharmaceuticals, Inc.
EYPT
President & CEO
20,000
0.0429%
$2.73$54,500-5.43%
2014-06-19SaleEyePoint Pharmaceuticals, Inc.
EYPT
President & CEO
6,138
0.0221%
$4.00$24,552+1.73%
2014-06-18SaleEyePoint Pharmaceuticals, Inc.
EYPT
President & CEO
3,931
0.0041%
$1.13$4,442+3.27%
2014-06-17SaleEyePoint Pharmaceuticals, Inc.
EYPT
President & CEO
9,000
0.0327%
$4.00$36,000+2.49%
2014-06-16SaleEyePoint Pharmaceuticals, Inc.
EYPT
President & CEO
6,400
0.0149%
$2.57$16,448+2.49%
2014-06-13SaleEyePoint Pharmaceuticals, Inc.
EYPT
President & CEO
4,400
0.0159%
$4.01$17,644+1.73%
2014-06-12SaleEyePoint Pharmaceuticals, Inc.
EYPT
President & CEO
19,200
0.0452%
$2.58$49,440+3.01%
2014-05-05SaleEyePoint Pharmaceuticals, Inc.
EYPT
President & CEO
7,000
0.0166%
$2.57$17,990+3.8%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.